Podcast thumbnail for TGen Talks

by TGen

5.0(7 reviews)
97 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
35

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality37
Social0
YouTube0
Engagement81

Podcast Overview

TGen Talks explores the human genome to tackle the latest science and discoveries in cancer, neurological disorders, rare diseases, metabolic disorders and infectious disease. Learn about causes and potential cures in our monthly podcast!

Language

🇺🇲

Publishing Since

12/5/2017

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

35

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality37
Social0
YouTube0
Engagement81
6
Excellent Areas
1
Good Performance
12
Growth Opportunities
excellent
Episode Length
18 minutes
Performing excellently!
good
Show Notes Quality
3.0/5

Recommendations available

Unlock the full report to see detailed tips

poor
Publishing Consistency
Every 32 days

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for TGen Talks

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Episode 93: Dr. John Fryer Discusses Mentorship in Biomedical Research

July 29, 2026

Episode 93: Dr. John Fryer Discusses Mentorship in Biomedical Research

In this episode of TGen Talks, we explore the art and responsibility of mentorship in biomedical research. Behind every breakthrough is not just data and experiments, but the guidance of seasoned scientists who shape the next generation. And while the results may not appear in a lab notebook, they’re just as important. TGen neuroscientist and educator, Dr. John Fryer, joins the podcast to share how mentorship transforms careers, fosters resilience, and sparks creativity. From the lessons learned in his own training to the values he instills in his lab today, Dr. Fryer reminds us that science is an apprenticeship at heart, and choosing the right mentor can make all the difference in the world. Because in the end, the breakthroughs we celebrate are powered not only by experiments, but by the people who take the time to guide others along the way.

Episode thumbnail for Episode 92: Helios Scholar  Saahithi Mallapragada

May 27, 2026

Episode 92: Helios Scholar Saahithi Mallapragada

For many Arizona students, the path into science begins with a single summer that reshapes their confidence and their future. Since 2007, the Helios Scholars Program at TGen has been that turning point. Each year, Helios Scholars spend eight weeks working directly with TGen researchers exploring cancer biology, neurological and infectious disease, diabetes, and the fast‑growing world of computational genomics. Some even step into administrative roles that keep scientific projects moving. The program began with a Helios Education Foundation grant in 2006. The pilot’s success led to a $6.5 million endowment and the official launch of Helios Scholars at TGen, a program built to educate, inspire, and strengthen Arizona’s STEM workforce. Now entering its 20th year, the impact is undeniable. Alumni have published research, earned national recognition, and joined top graduate and medical programs across the country. Helios alumna Saahithi Mallapragada joins TGen Talks to discuss how her Helios experience became a launchpad for her career in science. You’ll hear about her internship experience, her work in the lab, and why she would encourage anyone to apply to the Helios Scholar program to see if science might be a true passion.

Episode thumbnail for Episode 91: Drs. Simona Migliozzi and Luciano Garofano

May 1, 2026

Episode 91: Drs. Simona Migliozzi and Luciano Garofano

May is Brain Tumor Awareness Month. In this episode, meet two new TGen researchers whose shared love of science—and math—first brought them together in the lab and later in life. Drs. Simona Migliozzi and Luciano Garofano are married to each other and to their work. They discuss their education in Italy, their research journeys across institutions in the U.S., and the path that ultimately led them to TGen, where Dr. Garofano’s expertise in math and statistics pairs seamlessly with Dr. Migliozzi's passion for improving outcomes for patients with glioblastoma. You’ll also hear about their individual contributions to the growing body of GBM research and learn which partner believes the other is the true “smart one” in the partnership.

97 total episodes available

Deep-dive analytics for TGen Talks

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is TGen Talks?

TGen Talks explores the human genome to tackle the latest science and discoveries in cancer, neurological disorders, rare diseases, metabolic disorders and infectious disease. Learn about causes and potential cures in our monthly podcast!

How often does this podcast release new episodes?

This podcast updates bi-weekly.

Where can I listen to this podcast?

This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

No, this podcast does not typically feature guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.